MedTrace Logo

Effect of Extracorporeal Shockwave Therapy on Pruritus in Neurodermatitis Patients

NCT07206680 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2026-03-09

No results posted yet for this study

Summary

The purpose of this study is to evaluate the therapeutic effect of shockwave therapy on reducing pruritus in neurodermatitis patients.

Conditions

  • Neurodermatitis

Interventions

DEVICE

Shockwave therapy

The procedures for Extracorporeal Shockwave Therapy (ESWT) involve several steps. First, the patient is positioned comfortably, and the physiotherapist explains the treatment procedure. Before the session begins, the device cables are checked for proper functioning. The shockwave type used is Non-Focused/Radial, with a treatment duration not exceeding 10 minutes. The frequency is set at 4 Hz, and the intensity ranges from 0.05 to 0.20 mJ/mm². Each session involves a total of 1000 to 2000 shocks. The treatment consists of four sessions, each held once a week.

DRUG

Emollients & corticosteroids

Patients in both groups will receive emollients \& corticosteroids for one month.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Nessrien Afify Abd El Rashid, PhD · Assistant Professor, Cairo University

  • Noha Zakaria Tawfik, PhD · Assistant Professor, Suez Canal University

  • Doaa Atef Aly, PhD · Lecturer, Cairo university

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-15
Primary Completion
2025-09-15
Completion
2025-10-25

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07206680 on ClinicalTrials.gov